Outcome and factor | Atopic | Non-atopic |
Skin reactivity to mites
| | |
Mother with asthma | 3.9 (0.9–16.0) | |
Smoking | | 4.8 (1.7–13.8) |
Work-related rhinoconjunctivitis
| | |
Rhinitis on contact with pets | 4.2 (2.3–7.7) | |
Perannual rhinitis | 4.0 (2.1–7.4) | 2.4 (1.0–5.4) |
Respiratory symptoms on contact with pets | 2.6 (0.8–8.1) | 7.6 (1.2–47.5) |
Immediate skin reaction to pets | 4.6 (2.3–9.1) | |
PC20<32 mg·mL−1 | 1.8 (1.0–3.3) | 2.9 (1.3–6.3) |
PC20<8 mg·mL−1 | 1.9 (0.9–4.0) | 3.8 (1.3–10.8) |
Work-related respiratory symptoms
| | |
Hay fever | 6.1 (2.3–15.9) | |
Rhinitis on contact with pets | 33.4 (4.4–252.1) | |
Perannual rhinitis | 16.9 (2.2–127.3) | |
Respiratory symptoms on contact with pets | 8.7 (3.2–23.6) | |
Immediate skin reaction to pets | 13.5 (4.4–41.4) | |
PC20<32 mg·mL−1 | 8.0 (2.6–24.4) | |
PC20<8 mg·mL−1 | 4.3 (1.8–10.3) | |
Specific immunological sensitization
| | |
Hay fever | 4.0 (1.5–10.7) | |
Rhinitis on contact with pets | 4.0 (2.1–7.7) | |
Perannual rhinitis | 4.6 (2.2–9.5) | |
Respiratory symptoms on contact with pets | 5.1 (1.7–15.5) | |
Immediate skin reaction to pets | 3.4 (1.7–6.6) | |
PC20<32 mg·mL−1 | 4.0 (2.0–7.7) | |
PC20<8 mg·mL−1 | 2.9 (1.4–6.2) | |
Occupational rhinoconjunctivitis
| | |
Rhinitis on contact with pets | 3.9 (2.0–7.6) | |
Perannual rhinitis | 4.9 (2.2–11.1) | |
Respiratory symptoms on contact with pets | 2.4 (0.9–6.8) | |
Immediate skin reaction to pets | 5.6 (2.9–11.1) | |
PC20<32 mg·mL−1 | 3.6 (1.8–7.1) | 4.1 (1.1–15.2) |
PC20<8 mg·mL−1 | 2.6 (1.2–5.4) | |
Probable occupational asthma
| | |
Respiratory symptoms on contact with pets | 3.2 (1.1–9.7) | |
Immediate skin reaction to pets | 4.1 (1.6–10.2) | |